ABSTRACT
A retrospective analysis of all adverse experience reports received by the Australian Pesticides and Veterinary Medicines Authority's Adverse Experience Reporting Program for veterinary medicines since 1995, showed that permethrin toxicity in cats usually occurred after the owner applied a canine permethrin-containing product, typically a spot-on. Cats are also at risk from grooming or being in direct contact with recently treated dogs. This paper reviews permethrin toxicosis and its treatment in cats, incorporating information from the Australian and selected overseas veterinary pharmacovigilance programs.
Subject(s)
Adverse Drug Reaction Reporting Systems/statistics & numerical data , Cat Diseases/epidemiology , Insecticides/poisoning , Permethrin/poisoning , Animals , Cat Diseases/etiology , Cat Diseases/mortality , Cat Diseases/prevention & control , Cats , Poisoning/epidemiology , Poisoning/veterinary , Retrospective Studies , United Kingdom/epidemiologySubject(s)
Anti-Bacterial Agents/adverse effects , Horse Diseases/drug therapy , Legislation, Veterinary , Oxytetracycline/adverse effects , Animals , Anti-Bacterial Agents/therapeutic use , Australia , Drug Administration Routes/veterinary , Drug Interactions , Horses , Oxytetracycline/therapeutic useABSTRACT
OBJECTIVES: Chloroplatinates are potent allergens but other soluble platinum compounds such as tetraammine platinum dichloride (TPC) do not provoke reactions in subjects who are sensitive to chloroplatinates. TPC has been used in the manufacture of autocatalysts for 20 years. This study analyses 20 year data on exposure to soluble platinum compounds and medical surveillance to confirm that TPC is not allergenic. METHODS: Workers in three distinct operations were exposed to soluble platinum compounds as chloroplatinates, chloroplatinates with TPC, or to TPC alone. Results of personal air sampling for soluble platinum compounds were compared together with the results of medical surveillance. RESULTS: The levels of exposure to soluble platinum compounds in each operation were comparable but the incidence of allergy was significantly different. In a subgroup of workers consistently exposed to chemical processes in each operation, the cumulative chance of being sensitised after 5 years of exposure was estimated as 51% for chloroplatinate exposure, 33% for mixed exposure, and 0% for TPC alone. The differences in sensitisation rates could not be explained by age, sex, and atopy. Nor could they be explained by the increased frequency of smoking in the workers with chloroplatinate exposure, despite the markedly higher risk of sensitisation in smokers. The differences could only be explained by the chemical stability of TPC. CONCLUSIONS: This study shows that the soluble platinum compound TPC is not allergenic under normal industrial conditions. Characterisation of the chemical compound (speciation) is essential to prevent stringent exposure limits being imposed for all soluble compounds on a generic basis.
Subject(s)
Allergens/adverse effects , Drug Hypersensitivity/etiology , Metallurgy , Occupational Diseases/etiology , Platinum Compounds/adverse effects , Adolescent , Adult , Female , Humans , Male , Middle Aged , Occupational Exposure/adverse effects , Platinum Compounds/immunology , Population Surveillance , Retrospective StudiesABSTRACT
OBJECTIVE: To measure the incidence of platinum salt sensitivity (PSS) in refinery workers and examine the influence of cigarette smoking and exposure to platinum salts on sensitisation. DESIGN: A prospective cohort study with examination of workers at quarterly intervals for 18 months, and again at 24 months. SETTING: A South African primary platinum refinery. SUBJECTS: 78 new recruits, selected by the refinery's usual procedure, without apparent atopy and in good respiratory health. RESULTS: After 24 months 32 (41%) subjects had been diagnosed PSS and were subsequently medically separated. Twenty two (28%) cases were confirmed by positive skin prick test to platinum salts, 10 (13%) cases were symptomatic but skin prick negative. Incidence of cases per 100 person-months was 1.9 skin prick positive and 0.8 negative. Risk of sensitisation was about eight times greater for smokers than non-smokers, and six times greater for high exposure than low exposure. CONCLUSION: Smoking and intensity of exposure were definitely associated with development of PSS. Positive responses to platinum salt skin prick test had a 100% positive predictive value for symptoms and signs of PSS if exposure continued.
